Stroke News Archive
Investigators found a positive association between higher childhood BMI scores and early adult ischemic stroke.
Hepatitis C virus (HCV) infection may also increase the risk of stroke.
The incidence of intracerebral hemorrhage and subarachnoid hemorrhage was stable in both men and women.
THRIVE scores not only accurately predicted good and poor outcomes in stroke patients following IVT or ET, but also the degree of ischemia following these treatments.
Despite disappointing results, tenecteplase's story in stroke treatment might not be over.
Women and patients of African-American race face an increased risk of experiencing poststroke recrudescence.
There is an increased risk of a recurrent stroke after discontinuing statin therapy 3 to 6 months post initial ischemic stroke.
Only 16% of patients had an adequate response to conventional therapy, with patients who didn't considered "non-responders."
Less than half of individuals with ischemic stroke receive a prescription for statins.
Birthplace is a significant risk factor for dementia, even after adjusting for educational levels, race, and life-course vascular risk factors.
Subarachnoid hemorrhage must be ruled out in patients with acute onset of severe headache.
There are a limited number of prediction models that identify patients at risk of major bleeding after stroke or TIA.
The update focused on diagnosis of neuropathic pain in patients with spinal cord injury, stroke, or multiple sclerosis.
At 90-days, the rate of thrombotic events in both groups was low.
The Penumbra 3D revascularization device was recalled by the FDA because of a risk of the delivery wire breaking during use.
Rivaroxaban treatment for nonvalvular AF in patients with cancer is safe.
The risk of a second stroke or transient ischemic attack (TIA) remains considerable for at least 5 years after the first event.
Although spot sign predicted ICH expansion, it proved to be a less robust diagnostic marker than demonstrated by previous single-center cohort studies.
An increase in BMI during puberty and adolescence was associated with increase risk of stroke.
Reduced door-to-needle times have been shown to improve outcomes after stroke.
Patients with cirrhosis had a 2.17% per year incidence of stroke compared with 1.11% per year incidence of stroke in patients without cirrhosis.
Music-and-rhythm therapy has also been shown to help improve balance and memory.
Clinicians should make patients aware of their increased risk for stroke and heart attack.
Risk for symptomatic intracranial hemorrhage after endovascular treatment for acute ischemic stroke is significantly higher in real-world practice than rates reported by clinical trials.
Positioning of the head in acute ischemic stroke does not seem to affect recovery.
According to a study published in Stroke artificially-sweetened beverages is associated with increased risk of stroke and dementia.
Compared with other sources of ICH, those associated with arteriovenous malformations had lower odds of death.
Intracranial atherosclerosis was lower in patients with migraine compared with those without migraine.
Dual therapy was associated with a significantly higher bleeding risk.
Delays in anticoagulation treatment resulted in increased risk for dementia.
No between-group differences were observed for reperfusion success and mortality, among other measures.
Neglecting abnormalities in ECG readings could result in serious acute cardiac events in patients presenting with stroke.
Intensive antiplatelet therapy appears to reduce risk of recurrence immediately after stroke, but may pose risks further out.
New research from the American Heart and American Stroke Associations found that many Americans don't know the symptoms of stroke.
Findings from a new study suggest that engaging in stroke prevention strategies may help reduce the risk of dementia.
Men who received testosterone replacement therapy had lower odds of cardiovascular events.
Monitored anesthesia was found to be as safe and effective as general anesthesia in patients undergoing endovascular therapy for stroke.
E-health-based coagulation service was linked to lower frequency of adverse events, including thromboembolism, bleeding, and death.
The relative risk of developing ischemic stroke was increased in patients with systemic lupus erythematosus, especially within the first year after diagnosis.
Neurologists need to engage their emergency medicine colleagues to identify protocols and pathways for when to trigger appropriate neurological consultation or initiate acute stroke therapies.
During the study period, the percentage of people with 3 or more stroke risk factors roughly doubled for all age groups.
Previous studies have produced contradictory evidence of a link between serum UA and stroke risk, with some pointing to greater risks in women compared with men.
Over 32% of patients were functionally independent at 90 days and 37.1% were functionally independent at 2 years.
There is little data to support telestroke for IV thrombolysis administration in the extended time window of 3 to 4.5 hours after stroke onset.
Pulse pressure was associated with the risk for ischemic stroke in first-ever ischemic stroke patients old than 60 years.
Resumption of oral anticoagulants after intracerebral hemorrhage was found to improve outcomes at 1 year.
Mortality among women with preeclampsia and pregnancy-associated stroke was significantly higher than in controls.
Previous research had suggested that the benefits of IV tPA are diminished in patients weighing more than 100 kg.
Higher glucose levels reduce likelihood of good outcome among stroke patients with good collaterals.
Having sickle cell disease did not adversely affect any of the indicators the researchers measured.
Patients taking apixaban showed significantly less intracranial hemorrhage (0.33% per year) vs patients taking warfarin (0.80% per year), no matter the type and location.
Patients who exercised prior to their stroke were more likely to be able to perform basic and complex tasks after the stroke event.
The investigators reported no difference in 3-month mortality rates across all 5 studies included in the meta-analysis.
Use of mobile stroke units is associated with reduced time to imaging and thrombolysis compared with traditional care.
There is no urgency to administer preexisting antihypertensive therapy in the first few hours or days after stroke, unless indicated for other comorbid conditions.
A substantial number of strokes may be due to underuse of or inadequate anticoagulation in Afib.
Admission hyperglycemia was associated with poststroke infection, as well as 3-month functional outcome and mortality.
Results at 3 years for tenecteplase vs placebo in patients with intermediate-risk pulmonary embolism.
Recurrent fatal or nonfatal VTE occurred in 1.5% of patients who took 20 mg of rivaroxaban, 1.2% of patients who took 10 mg, and 4.4% who took aspirin.
Patients with inherited thrombophilias who did not undergo patent foramen ovale closure faced a significantly increased risk of stroke.
More than 80% of ischemic stroke patients weren't getting adequate anticoagulation therapy.
Up to 20% of stroke cases in young adults occur in those with cervical artery dissection, the leading cause of stroke in this population.
Clinicians should closely monitor patients with atrial fibrillation, especially if they are female and of increasing age.
Efficacy of triple antiplatelet therapy compared with current guideline-based therapy for the prevention of recurrent stroke was evaluated in the TARDIS trial.
The increase in usage of antithrombotics, especially vitamin K antagonists, has been linked to an increase in prevalence of subdural hematomas.
More patients receiving VNS experienced enhanced arm movement over a 90-day period.
Restarting anticoagulation after both nonlobar and lobar ICH was associated with decreased mortality.
Men were more likely than women to be treated with IV tPA within 30 minutes of arrival at a hospital.
As more patients survive ICH, emphasis is slowly shifting from survival to improving ICH-related morbidity and optimization of functional recovery.
The results provide good evidence for the use of contact aspiration in ischemic stroke.
Optimal antiplatelet treatment has yet to be determined for stroke survivors with prior intracerebral hemorrhage.
The co-presentation of headache at stroke onset in children may provide clues to underlying pathophysiologic mechanisms.
Psychological distress may cause changes within cells that trigger inflammation and oxidative stress, both of which are believed to increase stroke risk.
Delays related to the determination of treatment eligibility increased door-to-needle times by more than 30 minutes compared with patients with no delays.
Pulmonary embolism risk was lowest in patients with cerebral venous thromboembolism during the index hospitalization.
Neither lying flat nor sitting up appears to alter outcomes in patients presenting with acute stroke.
Among ICH survivors, 63% developed both depression and dementia during a 5-year follow-up study.
Standardized definitions were proposed for stroke, hypoxic-ischemic injury, and cerebral hemorrhage.
Early intervention in patients with heart failure or atrial fibrillation may help delay or prevent the onset of mild dementia.
Patients receiving treatment with vitamin K antagonists (VKA) or antiplatelet agents face a significantly increased risk of mortality within 24 hours of intracranial hemorrhage.
The difference in rate of recurrence of PCAIS may have to do with a difference in mechanism compared with ACAIS.
Use of advanced imaging may help predict which patients will have an optimal response to treatment with intravenous tissue plasminogen activator.
It is not clear if identifying atrial fibrillation in an effort to prevent stroke would be an effective preventive strategy.
Despite being more common than thought, many cases of neonatal hemorrhagic stroke remain idiopathic.
The use of combined hormonal contraceptives significantly increases the risk of ischemic stroke in women with migraine with aura but not in women with migraine without aura.
Migraine affects approximately 20% of the general population and is associated with an increased risk for ischemic stroke.
The increased risk of stroke was only observed among patients with diabetes controlled by insulin.
Using telestroke to evaluate patients with acute ischemic stroke eligible for thrombolysis provided access to acute stroke care in underserved areas.
A significant inverse trend was observed between the Healthy Nordic Food Index and risk of stroke.
Patients with elevated levels of activity in the amygdala were at higher risk for cardiovascular events.
Intravenous thrombolysis prior to mechanical thrombectomy did not benefit patients with acute ischemic stroke due to a large vessel occlusion.
Warfarin protected against ischemic stroke, major bleeding, and all-cause mortality in patients who continued to take the drug after dementia diagnosis.
Streptococcus mutans may raise the risk of cerebral microbleeds and stroke.
Concomitant use of oral anticoagulants contributed to a significantly higher increased risk for ICH.
Risk of stroke is greatest in the first 2 days after the intervention, then gradually decreases.
At 1 year, no difference in complications was observed between the 2 age groups.
Twelve months after AFib ablation, risk of recurrent stroke or AFib is low.
Beate Diehl, MD, PhD, FRCP, discusses her research on post-stroke epilepsy.
The triple-validated SeLECT score may help identify patients suited for antiepileptic drug trials.
Patients with lesions in the left basal ganglia were more likely to have post-stroke epilepsy.
Neurology Advisor Articles
- Increased Mortality in Parkinson's Disease Linked to Low Antidepressant Adherence
- Age, Gender, and Cognition Predict Weight Loss in Parkinson's Disease
- MRI in Parkinson's Disease: Expanding Usability for Better Diagnostics
- Parkinson's: Sleep Disturbances Affect Clinical Motor Subtypes, Disability
- The Handoff: Your Week in Neurology News - 9/21/17
- Exenatide Presents Exciting Therapeutic Possibilities for Parkinson's Disease
- Cognitive Decline Related to Site Specific Mid-Life Adiposity
- Parkinson's, REM Sleep Disorder Combination Linked to Cognitive Decline
- Higher Doses of Pregabalin for Neuropathic Pain: Is it Safe?
- Buccal, Nasal Midazolam Most Cost-Effective for Pediatric Status Epilepticus
- Zika Virus Associated With High Risk for Neurologic Complications in Adults
- Evolocumab Has No Effect on Cognition in Patients Attaining Very Low Levels of LDL Cholesterol
- Acute Oxygen Therapy for Cluster Headahce Not Prohibitively Expensive
- β-2 Adrenergic Agonists Linked to α-synuclein Transcription and Risk of PD
- Little Evidence to Support Doctor, Patient Electronic Communication Guidelines